Elsevier’s Oncology Journal Network highlights

Welcome to our special article collection, curated to recognise Cancer Survivor Month. We invite you to explore these articles.

National Cancer Survivor Month June 2024

Cancer Pathogenesis and Therapy

• ●

  Factors affecting the place of death in patients with liver cancer in China, 2013–2020: A population-based studyopens in new tab/window

• ●

  Breast cancer risk associated with BRCA1 and BRCA2 pathogenic variants in the Eastern Chinese populationopens in new tab/window

• ●

  Fecal methylated syndecan-2 (SDC2) testing for early screening of colorectal cancerous and precancerous lesions: A real-world retrospective study in Chinaopens in new tab/window

• ●

  Clinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005–2018)opens in new tab/window

Clinical Breast Cancer

• ●

  Survivorship Navigation for Young Women With Early-Stage Breast Canceropens in new tab/window

• ●

  Psychological Coping Factors Associated With Breast Cancer-Related Fatigue: A Systematic Review of Recent Evidence for Stages 0 to IIIopens in new tab/window

Clinical Colorectal Cancer

• ●

  Life After Colorectal Cancer: Survivorship the Road Less Traveledopens in new tab/window

• ●

  Colon Cancer Survivorship in Patients Who Have Received Adjuvant Chemotherapyopens in new tab/window

Clinical Genitourinary Cancer

• ●

  Association of Baseline Pre-Diagnosis and Post-Diagnosis Obesity and Weight Change with Cardiovascular Risk and Survival Among Nonmetastatic Prostate Cancer Survivorsopens in new tab/window

• ●

  Enhanced Prognostic Factors for Disease-Free Survival in Penile Squamous Cell Carcinoma: Insights from Songklanagarind Hospitalopens in new tab/window

Clinical Lung Cancer

• ●

  Lung Cancer in Women: The Past, Present, and Futureopens in new tab/window

• ●

  Real-World Neoadjuvant Treatment Patterns and Outcomes in Resected Non–Small-Cell Lung Canceropens in new tab/window

Clinical Lymphoma Myeloma Leukemia

• ●

  Listening to What Matters Most: Consumer Endorsed Patient Reported Outcome Measures (PROMs) for Use in Multiple Myeloma Clinical Trials: A Descriptive Exploratory Studyopens in new tab/window

• ●

  Overall Survival in Patients With Multiple Myeloma in the U.S.: A Systematic Literature Review of Racial Disparitiesopens in new tab/window

Gynecologic Oncology

• ●

  Mixed-method approach to informing a lifestyle intervention to improve the survivorship of patients with endometrial canceropens in new tab/window

• ●

  Impact of disease recurrence on the supportive care needs of patients with ovarian cancer and their caregiversopens in new tab/window

Gynecologic Oncology Reports

• ●

  Prior authorization for FDA-approved PARP inhibitors in ovarian canceropens in new tab/window

• ●

  Long-term disease-free survival with chemotherapy and pembrolizumab in a patient with unmeasurable, advanced stage dedifferentiated endometrial carcinomaopens in new tab/window

JACC: CardioOncology

• ●

  Time-Restricted Eating to Reduce Cardiovascular Risk Among Older Breast Cancer Survivors: A Single-arm Feasibility Studyopens in new tab/window

• ●

  Cardiovascular Risk Factors Disparities in Adult Survivors of Childhood Cancer Compared with the General Populationopens in new tab/window

Neoplasia

• ●

  Genomics driven precision oncology in advanced biliary tract cancer improves survivalopens in new tab/window

• ●

  Mutational signatures and their association with survival and gene expression in urological carcinomasopens in new tab/window

Elsevier’s Oncology Journal Network